Cancer News and Research

Latest Cancer News and Research

New material emits long-lasting, near-infrared glow after sunlight exposure

Materials that emit visible light after being exposed to sunlight are commonplace and can be found in everything from emergency signage to glow-in-the-dark stickers. But until now, scientists have had little success creating materials that emit light in the near-infrared range, a portion of the spectrum that only can be seen with the aid of night vision devices.

21 Nov 2011

Promising results from dexpramipexole phase 2 trial on ALS

Treatment with dexpramipexole - a novel drug believed to prevent dysfunction of mitochondria, the subcellular structures that provide most of a cell's energy - appears to slow symptom progression in the neurodegenerative disease amyotrophic lateral sclerosis (ALS). Promising results of a phase 2 trial of dexpramipexole are receiving advance online publication in Nature Medicine.

20 Nov 2011

Two genetic rearrangements may trigger 5 to 7% of breast cancers

Researchers at the University of Michigan Comprehensive Cancer Center have discovered two cancer-spurring gene rearrangements that may trigger 5 to 7 percent of all breast cancers.

20 Nov 2011

Omega-3 linked with reduced joint pain and cognitive side effects of breast cancer therapy

"I know I need this medicine to help lower my chance of cancer recurrence, but it makes my joints ache and stiff. It makes me feel old and I am not sure I can take this medication much longer."

19 Nov 2011

Combo hormone therapy increases risk of breast cancer in women with new-onset tenderness

The debate about using menopausal hormone therapies to relieve symptoms in post-menopausal women has been ongoing. Is the combination therapy of estrogen and progestin better or worse than just giving women estrogen alone? In women who still have a uterus (those who have not had a hysterectomy), progestin counteracts the increased risk of uterus cancer when estrogen is given alone, but at the expense of an increase in breast cancer risk compared to estrogen alone.

19 Nov 2011

Roundup: Fla. Medicare HMO closed; Tufts and BCBS resume talks

Quality Health Plans, a Medicare HMO with 10,000 Florida members, has been ordered into liquidation after failing to come up with the cash reserves the state says were needed. Its members will be moved to another -- still unnamed -- plan by Dec. 1.

19 Nov 2011

Outreach program director at CINJ to take part in unique cancer control program

Kiameesha Evans, MPH, MCHES, program director of the Office of Community Outreach at The Cancer Institute of New Jersey (CINJ), has been selected to take part in a unique pilot program for cancer control practitioners through the National Cancer Institute.

19 Nov 2011

Avastin drug not safe and effective for breast cancer patients: FDA Commissioner

FDA Commissioner Margaret A. Hamburg, M.D., said today she is revoking the agency's approval of the breast cancer indication for Avastin (bevacizumab) after concluding that the drug has not been shown to be safe and effective for that use.

19 Nov 2011

GAVI Alliance to fund roll-out of vaccines against cervical cancer, rubella in developing countries

The GAVI Alliance "has agreed to fund the roll-out of vaccines against cervical cancer in developing countries, offering protection against a disease that kills one woman every two minutes," Reuters reports.

19 Nov 2011

FDA approves EUSA's orphan drug ERWINAZE for acute lymphoblastic leukemia

EUSA Pharma, a transatlantic specialty pharmaceutical company focused on oncology, oncology supportive care and critical care, today announced that the US Food and Drug Administration (FDA) has approved its orphan drug ERWINAZE (asparaginase Erwinia chrysanthemi) for the treatment of acute lymphoblastic leukemia (ALL) in patients with hypersensitivity to E. coli-derived asparaginase.

19 Nov 2011

Model NYC program aims to address growing disparities in colon cancer mortality rates

Since the 1970s, U.S. mortality rates due to colorectal cancer have declined overall, yet among blacks and Hispanics, the death rates rose. Evidence suggests that underuse of colonoscopy screening among these groups is one reason for the large disparities. In 2003, New York City launched a multifaceted campaign to improve colonoscopy rates among racial and ethnic minorities and women.

19 Nov 2011

FAMEDS founder condemns FDA decision on Avastin for metastatic breast cancer

Breast cancer patients, their families and advocates expressed extreme disappointment at today's Food and Drug Administration (FDA) decision to remove the anti-cancer drug Avastin from the approved medication list for treatment of late stage breast cancer.

19 Nov 2011

New, incision-free surgery to manage chronic acid reflux

Adam Vasser would wake up at night choking on partially digested food and liquid. Stomach acid burned the delicate tissue of his throat. "I'd sleep really badly," he said. During the day, he sometimes suffered from heartburn.

19 Nov 2011

Wake Forest Baptist, VA partner to advance treatment of PTSD and TBI

Researchers at Wake Forest Baptist Medical Center and the U.S. Department of Veterans Affairs (VA) are teaming up for a research project aimed at advancing the treatment of military personnel suffering from post-traumatic stress disorder (PTSD) and traumatic brain injury.

19 Nov 2011

FDA revokes approval of Avastin for breast cancer

The commissioner of the Food and Drug Administration on Friday revoked the approval of the drug Avastin as a treatment for breast cancer, ruling in an emotional issue that pitted the hopes of some desperate patients against the statistics of clinical trials.

19 Nov 2011

Celerus Diagnostics receives three U.S. patents that cover key cancer technologies

Celerus Diagnostics, developer of the Wave RPD System and global leader in rapid immunohistochemistry for cancer diagnosis, announced today that the Company has been issued three important patents by the United States Patent and Trademark Office.

19 Nov 2011

CHCWM, Priority Health partner to explore oncology patient-centered medical home

In keeping with society's urgent need for more efficient and effective health care, Priority Health and Cancer and Hematology Centers of West Michigan (CHCWM) have joined forces to explore an innovative oncology patient-centered medical home.

19 Nov 2011

Pfizer receives 2011 Business Civic Leadership Center's Corporate Citizenship Award

Pfizer Inc. today announced that it has received the 2011 Business Civic Leadership Center's Corporate Citizenship Award in the Best International Ambassador category for Pfizer's Global Health Partnerships program.

19 Nov 2011

FDA approves EYLEA for treatment of wet Age-related Macular Degeneration

Regeneron Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has approved EYLEA (aflibercept) Injection, known in the scientific literature as VEGF Trap-Eye, for the treatment of patients with neovascular (wet) Age-related Macular Degeneration (AMD) at a recommended dose of 2 milligrams every four weeks for the first 12 weeks, followed by 2 mg every eight weeks.

19 Nov 2011

Senator Klein opens new Cognitive Neurophysiology Laboratory at Albert Einstein College of Medicine

New York State Senator Jeffrey D. Klein joined administrators and faculty members of Albert Einstein College of Medicine of Yeshiva University last Friday to officially open their new Cognitive Neurophysiology Laboratory.

19 Nov 2011

Cancer News and Research

Latest Cancer News and Research

New material emits long-lasting, near-infrared glow after sunlight exposure

Promising results from dexpramipexole phase 2 trial on ALS

Two genetic rearrangements may trigger 5 to 7% of breast cancers

Omega-3 linked with reduced joint pain and cognitive side effects of breast cancer therapy

Combo hormone therapy increases risk of breast cancer in women with new-onset tenderness

Roundup: Fla. Medicare HMO closed; Tufts and BCBS resume talks

Outreach program director at CINJ to take part in unique cancer control program

Avastin drug not safe and effective for breast cancer patients: FDA Commissioner

GAVI Alliance to fund roll-out of vaccines against cervical cancer, rubella in developing countries

FDA approves EUSA's orphan drug ERWINAZE for acute lymphoblastic leukemia

Model NYC program aims to address growing disparities in colon cancer mortality rates

FAMEDS founder condemns FDA decision on Avastin for metastatic breast cancer

New, incision-free surgery to manage chronic acid reflux

Wake Forest Baptist, VA partner to advance treatment of PTSD and TBI

FDA revokes approval of Avastin for breast cancer

Celerus Diagnostics receives three U.S. patents that cover key cancer technologies

CHCWM, Priority Health partner to explore oncology patient-centered medical home

Pfizer receives 2011 Business Civic Leadership Center's Corporate Citizenship Award

FDA approves EYLEA for treatment of wet Age-related Macular Degeneration

Senator Klein opens new Cognitive Neurophysiology Laboratory at Albert Einstein College of Medicine

Industry Focus eBook - Oncology (1st Edition) eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Oncology (1st Edition) eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in